Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 11 of 11 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company APIE Therapeutics Inc. | Activity: Research and Development | Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. | Location Research Triangle Park |
| |
Company Artiam Bio Inc. | Activity: Research and Development | Company Description Artiam Bio is targeting the endocannabinoid system to treat diseases using pharmacology and medicinal chemistry approaches. Artiam Bio is initially focused on non-alcoholic and alcoholic liver diseases, Prader Willi syndrome and cannabis use disorder. | Location Morrisville |
| |
Company CMP Pharma Inc. | Activity: Production and Manufacturing | Company Description CMP develops, manufactures and commercializes niche oral liquid medications that address the needs of patients with difficulty swallowing solid dosage forms. | Location Farmville |
| |
Company Gusto Global LLC | Activity: Research and Development | Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. | Location Research Triangle Park |
| |
Company Kriya Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Kriya Therapeutics develops AAV-based gene therapies for the treatment of type 1 and type 2 diabetes, severe obesity, thyroid eye disease (TED) and other indications. This location is the company's internal manufacturing facility. | Location Morrisville |
| |
Company Metabolon Inc. | Activity: Contract Research and Testing | Company Description Metabolon is advancing the science of metabolomics for the clinic and life sciences research. Its technology and data are used for biomarker discovery, diagnostic test development, and genomics and population health initiatives. | Location Morrisville |
| |
Company Novo Nordisk Pharmaceutical Industries LP (Durham) | Activity: Production and Manufacturing | Company Description Novo Nordisk manufactures tablets for an oral GLP-1 treatment for type 2 diabetes. | Location Durham |
| |
Company Precision Diabetes Inc. | Activity: Sales and Operations | Company Description Precision Diabetes is developing a spectrum of unique diabetes tests, from detecting the risk of developing diabetes to diagnosing complications from diabetes. | Location Cary |
| |
Company SNP Therapeutics LLC | Activity: Research and Development | Company Description SNP Therapeutics develops genetic tests to identify genetic variant patterns that contribute to disease. SNPT also designs nutritional therapeutics to treat metabolic disorders. | Location Kannapolis |
| |
Company Vogenx Inc. | Activity: Research and Development | Company Description Vogenx is a clinical stage pharmaceutical company developing a molecule to address post-bariatric hypoglycemia. | Location Durham |
| |
Company vTv Therapeutics LLC | Activity: Research and Development | Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. | Location High Point |